Cargando…

Systematic review of clinical guidelines for lipid lowering in the secondary prevention of cardiovascular disease events

BACKGROUND: The WHO recommends that those with established cardiovascular disease should be treated with lipid-lowering therapy, but there is no specific guidance regarding lipid monitoring. Unnecessary general practitioner visits may be a burden for patients and increase healthcare costs. A systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Rosemary Elisabeth, Welsh, Paul, Logue, Jennifer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751215/ https://www.ncbi.nlm.nih.gov/pubmed/33443127 http://dx.doi.org/10.1136/openhrt-2020-001396

Ejemplares similares

Residual cardiovascular risk in individuals on lipid-lowering treatment: quantifying absolute and relative risk in the community
por: Lieb, Wolfgang, et al.
Publicado: (2018)

Machine learning approaches improve risk stratification for secondary cardiovascular disease prevention in multiethnic patients
por: Sarraju, Ashish, et al.
Publicado: (2021)

Change in cardiovascular risk assessment tool and updated Norwegian guidelines for cardiovascular disease in primary prevention increase the population proportion at risk: the Tromsø Study 2015–2016
por: Nilsen, Amalie, et al.
Publicado: (2021)

Longitudinal associations between loneliness, social isolation and cardiovascular events
por: Bu, Feifei, et al.
Publicado: (2020)

Outcomes of an integrated community-based nurse-led cardiovascular disease prevention programme
por: Connolly, S B, et al.
Publicado: (2017)

Research priorities relating to the delivery of cardiovascular prevention and rehabilitation programmes: results of a modified Delphi process
por: McHale, Sheona, et al.
Publicado: (2023)

Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020)

Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
por: Gynnild, Mari Nordbø, et al.
Publicado: (2022)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
por: Miri, Yasmin, et al.
Publicado: (2021)

Association between exercise habit changes and mortality following a cardiovascular event
por: Kang, Dong-Seon, et al.
Publicado: (2022)

Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Lower birth weight is linked to poorer cardiovascular health in middle-aged population-based adults
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies
por: Arnaout, Rima, et al.
Publicado: (2019)

Cardiovascular risk factors and autonomic indices in relation to fatal and non-fatal coronary events
por: Zambach, Christian, et al.
Publicado: (2021)

Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Mortality and high risk of major adverse events in patients with COVID-19 and history of cardiovascular disease
por: Tessitore, Elena, et al.
Publicado: (2021)

Identification of an increased lifetime risk of major adverse cardiovascular events in UK Biobank participants with scoliosis
por: Quintero Santofimio, Valentina, et al.
Publicado: (2023)

ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK
por: Jennings, Catriona S, et al.
Publicado: (2020)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Systematic screening for cardiovascular risk at pharmacies
por: Rohla, Miklos, et al.
Publicado: (2016)

Impact of changes in heart rate with age on all-cause death and cardiovascular events in 50-year-old men from the general population
por: Chen, Xiao-jing, et al.
Publicado: (2019)

Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies
por: Cheng, Kevin, et al.
Publicado: (2015)

Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality
por: Milojevic, Ai, et al.
Publicado: (2014)

Association of Life’s Simple 7 and ideal cardiovascular health in American Indians/Alaska Natives
por: Rawal, Smita, et al.
Publicado: (2023)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors
por: Matthews, Anthony A, et al.
Publicado: (2021)

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)

Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
por: Curneen, James MG, et al.
Publicado: (2021)

The importance of early life family factors in the association between cardiovascular risk factors and early cardiovascular mortality
por: Kjøllesdal, Marte K R, et al.
Publicado: (2017)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Nut consumption and incidence of seven cardiovascular diseases
por: Larsson, Susanna C, et al.
Publicado: (2018)

Low prevalence of ideal cardiovascular health in Peru
por: Benziger, Catherine P, et al.
Publicado: (2018)

COVID-19 and its impact on the cardiovascular system
por: Khawaja, Saud Ahmed, et al.
Publicado: (2021)

Harnessing digital health to optimise the delivery of guideline-based cardiac rehabilitation during COVID-19: an observational study
por: Gibson, Irene, et al.
Publicado: (2023)

The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction
por: Attard, Ritienne, et al.
Publicado: (2017)

Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018)

Convalescent troponin and cardiovascular death following acute coronary syndrome
por: Adamson, Philip D, et al.
Publicado: (2019)

Ergothioneine is associated with reduced mortality and decreased risk of cardiovascular disease
por: Smith, Einar, et al.
Publicado: (2020)

Association between combat-related traumatic injury and cardiovascular risk
por: Boos, Christopher J, et al.
Publicado: (2022)

Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank
por: Raisi-Estabragh, Zahra, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h6h4o3tftab9ims389k0q08uuh